Biotechnology company Onyx Pharmaceuticals Inc. said Thursday it plans to provide an update on Nexavar, a cancer drug for which the company is seeking additional Food and Drug Administration approval.
Biotechnology company Onyx Pharmaceuticals Inc. said Thursday it plans to provide an update on Nexavar, a cancer drug for which the company is seeking additional Food and Drug Administration approval.